In re Blue Cross Blue Shield Antitrust Litigation
This text of 908 F. Supp. 2d 1373 (In re Blue Cross Blue Shield Antitrust Litigation) is published on Counsel Stack Legal Research, covering United States Judicial Panel on Multidistrict Litigation primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
TRANSFER ORDER
Before the Panel:
[1375]*1375According to defendants, BCBSA is a coordinated effort by health insurers to create a national brand with separate companies in local areas. In total, 38 separate Blue Plans operate under Blue Cross Blue Shield trademarks and trade names, providing health insurance to approximately 100 million subscribers. Plaintiffs contend that the 38 Blue Plans are independent health insurance companies that, but for any agreement to the contrary, could and would compete with one another. Instead, working together with and through the BCBSA, they have allegedly divided and allocated among themselves health insurance markets throughout the nation to eliminate competition. Plaintiffs variously contend that this conduct violates Sections 1 and 2 of the Sherman Antitrust Act, as well as various related state laws.
Plaintiffs in the Northern District of Alabama Conway action, the Western District of Tennessee Morrissey action and three potential tag-along actions support the plaintiffs’ motion in its entirety, as do responding defendants.2 Plaintiffs in three Northern District of Alabama actions — Carter, Richards and American Electric Motor — oppose centralization. Plaintiffs in the Northern District of Alabama Bajalieh and One Stop Environmental actions and the Western District of North Carolina Cerven action also oppose centralization and, alternatively, suggest centralization in the Northern District of Alabama or the Western District of North Carolina.
The primary arguments advanced against centralization are that there are too few pending actions, discovery will focus on each Blue Plan’s activity in a specific market, and several potentially-dispositive state-specific issues will be prominent in each action. We disagree that these considerations weigh against centralization here. Though only nine actions pending in three districts were included on the motion for centralization, this litigation has since grown to encompass potentially 21 actions involving allegations of complex anticompetitive behavior pending in fourteen districts. The Panel has, in the past, centralized antitrust cases involving allegations of concerted anticompetitive activity in the insurance market. See, e.g., MDL No. 767 — In re: Commercial Gen. Liab. Ins. Antitrust Litig., Aug. 30, 1988, Transfer Order at 2 (“The complaints in all actions contain similar allega[1376]*1376tions of conspiracies, involving essentially the same groups of defendants, to manipulate the availability of commercial general liability insurance, in violation of federal antitrust laws.”). Transfer under Section 1407 does not require a complete identity of common factual issues as a prerequisite to transfer, and the presence of additional facts or differing legal theories is not significant when the actions still arise from a common factual core. Here, the actions involve substantial common questions of fact relating to the state BCBS entities’ relationship with the national association, BCBSA, and the licensing agreements that limit the Blue Plans’ activity to exclusive service areas, among other restrictions. All of the Blue Plans are alleged to be co-conspirators, even though some Blue Plans are named as defendants only in actions in their respective state. Centralizing these actions under Section 1407 will ensure streamlined resolution of this litigation to the overall benefit of the parties and the judiciary.
For all these reasons, on the basis of the papers filed and hearing session held, we find that these actions involve common questions of fact, and that centralization of all actions in the Northern District of Alabama will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. Centralization will eliminate duplicative discovery; prevent inconsistent pretrial rulings, including with respect to class certification; 3 and conserve the resources of the parties, their counsel, and the judiciary.
Weighing all factors, we have selected the Northern District of Alabama as the transferee district for this litigation. Seven related actions are pending in this district, and these actions include claims on behalf of both Blue Plan subscribers and healthcare providers. Further, the Honorable R. David Proctor, to whom we assign this litigation, is an experienced transferee judge who is already familiar with the contours of the litigation and has taken preliminary steps to organize the litigation.
IT IS THEREFORE ORDERED that pursuant to 28 U.S.C. § 1407, the actions listed on Schedule A and pending outside the Northern District of Alabama are transferred to the Northern District of Alabama and, with the consent of that court, assigned to the Honorable R. David Proctor for coordinated or consolidated pretrial proceedings with the action pending there.
SCHEDULE A
MDL No. 2406 — IN RE: BLUE CROSS BLUE SHIELD ANTITRUST LITIGATION
Northern District of Alabama
Fred R. Richards, et al. v. Blue Cross and Blue Shield of Alabama, et al., C.A. No. 2:12-01133
One Stop Environmental, LLC, et al. v. Blue Cross and Blue Shield of Alabama, et al., C.A. No. 2:12-01910
American Electric Motor Services, Inc. v. Blue Cross and Blue Shield of Alabama, et al., C.A. No. 2:12-02169
Chris Bajalieh, et al. v. Blue Cross and Blue Shield of Alabama, et al., C.A. No. 2:12-02185
GC Advertising, LLC, et al. v. Blue Cross and Blue Shield of Alabama, et al., C.A. No. 2:12-02525
Jerry L. Conway v. Blue Cross and Blue Shield of Alabama, et al., C.A. No. 2:12-02532
Thomas A. Carder, et al. v. Blue Cross and Blue Shield of Alabama, et al., C.A. No. 2:12-02537
[1377]*1377 Western District of North Carolina
Thomas A. Cerven, Jr., et al. v. Blue Cross and Blue Shield of North Carolina, et al., C.A. No. 5:12-00017
' Western District of Tennessee
Mary Morrissey v. Blue Cross Blue Shield of Tennessee, Inc., C.A. No. 2:12-02359 •
All Panel members have interests that would normally disqualify them under 28 U.S.C. § 455 from participating in the decision of this matter; they have renounced any interest in the underlying litigation.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
908 F. Supp. 2d 1373, 2012 WL 6554004, 2012 U.S. Dist. LEXIS 177691, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-blue-cross-blue-shield-antitrust-litigation-jpml-2012.